The Vanguard U.S. Minimum Volatility ETF (VFMV) is recommended as a Buy for moderately conservative investors seeking U.S. equity exposure with reduced volatility. Its actively managed, rules-based strategy focuses on diversification, lower valuations, and exposure across multiple market caps, helping it outperform the Russell 3000 benchmark during market downturns. Over the past year, VFMV returned 16.78%, beating the Russell 3000 by 4.79%. However, it may underperform in strong bull markets and has risks like low dividend yield and variability from active management. Overall, VFMV provides compelling downside protection for cautious investors.
Vanguard U.S. Minimum Volatility ETF (VFMV) offers insights for cautious investors. For readers following U.S. stocks, here is Pluang's market snapshot as of Nov 11, 2026 13:31 WIB: Out of 150 priced US stocks, 91 rose and 55 fell. Notable movers include HPE at USD 50.44 with a 5.16% increase and 94% buy orders, ASX at USD 37.28 up 5.07% with 87% buy orders, and AMAT at USD 390.00 rising 4.69% but with 64% sell orders. Typical hold times range from 35 to 68 days on Pluang.
Rakuten Kobo's 2026 annual report highlights a shift in global reading habits towards niche communities and diverse genres like sports romances, dark romance, and cozy mysteries. The report notes the fragmentation of traditional bestseller lists as r...
Anthropic, an AI company, is reserving up to 20% of its initial public offering (IPO) shares specifically for retail investors. This allocation is significantly higher than the typical 5% to 10% usually offered to individual investors in IPOs. By doi...
DataParser by 17a-4 LLC now supports capturing Zoom AI meeting summaries along with transcripts and recordings for regulatory compliance. This solution helps firms retain, supervise, and search AI-generated content, closing gaps in archiving platform...
At the 9th China International Import Expo (CIIE), Shanghai Zhenhua Heavy Industries (ZPMC) signed import procurement contracts worth RMB 2.835 billion with 12 overseas suppliers including Siemens and ABB. This brings ZPMC's cumulative procurement co...
Devia, an AI platform spun out from Visium, has launched to help biopharma companies, CDMOs, and CROs manage GxP quality deviations more efficiently. It automates the entire deviation lifecycle from reporting to root cause analysis and CAPA, reducing...
